Company signals · MedTech
Renishaw
1 signal in the current window, with MitchelLake's leadership read on each.
Market context: The wider read — a Talent Market Index of 98.6 (Neutral), down 1.4 month-on-month — shows EMEA signal flow steady (-1.1pts).
Renishaw: 1 signal in the last 90 days — in line with the MedTech median of 1 across 18 tracked companies; 0.1% of MitchelLake's EMEA signal flow.
Signals at Renishaw
More signals across MedTech
Product Launch · EMEA
Abbott →Abbott launched CE-marked dual glucose-ketone Libre Duo sensors in Europe through expanded partnership with MiniMed, representing first-of-its-kind dual-analyte diabetes technology
Partnership · EMEA
Cepheid →Cepheid launched landmark 30-month study with the Fleming Initiative at London NHS Trusts to evaluate rapid CPE screening for drug-resistant infections
Product Launch · EMEA
ZEISS Medical Technology →ZEISS successfully completed early clinical implantations of AT LUCIA toric 721P intraocular lens across six European countries. Product is CE marked and expected to launch commercially in select European markets later in 2026.
Ma Activity · EMEA
Medtronic →Medtronic completed its acquisition of Scientia Vascular, integrating neurovascular access and therapeutic portfolios.
Product Launch · EMEA
Sonova →Sonova aims for cochlear implant market comeback with new technology after experiencing sales slump
Partnership · EMEA
Sectra →Sectra signed contract to deliver enterprise imaging cloud service to six NHS Trusts in London
Intelligence powered by Autonodal ↗